In addition, higher levels of SATB1 expression were associated with many other types of cancer, including laryngeal squamous cell carcinoma [19], endometrioid endometrial cancer [20], hepatocellular carcinoma [21], rectal cancer [22], cutaneous malignant melanoma [23], gastric cancer [24], [25], ovarian cancer [26], prostate cancer [27], lung cancer [28] and glioma [29]. This evidence concerns the gene SATB1 and central nervous system cancer.